SCHEMBL6628762

SCHEMBL6628762

C[C](C)Cc1ccc2[nH]cc(C(N)=O)c2c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
ATM Q13315 1/20 0.51
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
GABRA1 P14867 3/20 0.45
GABRB2 P47870 3/20 0.45
LMNA P02545 2/20 0.44
RAB9A P51151 2/20 0.44
NHERF1 O14745 2/20 0.42
F7 P08709 1/20 0.42
F3 P13726 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
MEN1 O00255 1/20 0.42
MITF O75030 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13267222 0.85 GABRA1 (0.60) ALDH1A1ATMHTR1DHTR1BGABRA1
SCHEMBL30934603 0.79 F7 (0.55) ALDH1A1GABRA1GABRB2LMNARAB9A
SCHEMBL25253727 0.79 F7 (0.55) ALDH1A1GABRA1GABRB2LMNARAB9A
SCHEMBL4232312 0.78 KDM4E (0.57) ALDH1A1GABRA1GABRB2LMNARAB9A
SCHEMBL7222371 0.77 HTR1D (0.51) ALDH1A1ATMHTR1DHTR1BGABRA1
SCHEMBL8109983 0.76 NR4A2 (0.67) ALDH1A1ATMHTR1DLMNARAB9A
SCHEMBL2546826 0.74 ALDH1A1 (0.61) ALDH1A1ATMHTR1DHTR1BLMNA
SCHEMBL3389562 0.74 ALDH1A1 (0.61) ALDH1A1ATMHTR1DHTR1BLMNA
SCHEMBL3169718 0.74 ALDH1A1 (0.49) ALDH1A1ATMGABRA1GABRB2NHERF1
SCHEMBL3590666 0.73 F7 (0.75) ALDH1A1ATMGABRA1GABRB2NHERF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1418916-A1 2-AMINO-4-HETEROARYLAMINOPYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Amgen Inc. (US) 2004-05-19 EP disclosed
WO-2003018022-A1 2-AMINO-4-HETEROARYLAMINOPYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER AMGEN INC. (US) 2003-03-06 WO disclosed